Illumina Inc (ILMN)

ILMN (NASDAQ:Drugs)
$189.12
pos +0.00
+0.00%
Today's Range: 185.84 - 189.42 | ILMN Avg Daily Volume: 1,182,700
Last Update: 10/24/14 - 3:59 PM EDT
Volume: 0
YTD Performance: 71.01%
Open: $0.00
Previous Close: $185.84
52 Week Range: $91.03 - $190.86
Oustanding Shares: 139,400,000
Market Cap: 25,906,096,000
6-Month Chart
TheStreet Ratings Grade for ILMN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 10 10 9
Moderate Buy 0 0 0 0
Hold 6 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.67 1.89 1.89 1.94
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 126.42
Price Earnings Comparisons:
ILMN Sector Avg. S&P 500
126.42 96.90 28.06
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
10.08% 103.77% 558.50%
GROWTH 12 Mo 3 Yr CAGR
Revenue 23.70 0.57 0.16
Net Income -17.20 0.00 0.00
EPS -20.90 -0.01 0.00
Earnings for ILMN:
EBITDA 0.26B
Revenue 1.42B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $0.78 $0.72 $2.64 $3.16
Number of Analysts 13 8 14 14
High Estimate $0.79 $0.76 $2.66 $3.28
Low Estimate $0.76 $0.67 $2.63 $2.97
Prior Year $0.45 $0.53 $1.80 $2.64
Growth Rate (Year over Year) 72.31% 36.56% 46.87% 19.37%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Trends have a great tendency to persist.
And no one thinks it's going to be easy to navigate.
Bullish
Oct 21, 2014 | 7:13 AM EDT
Shares of ILMN now seen reaching $245, according to JMP Securities. Estimates also increased, as the company is seeing higher demand ac...
Bullish
Oct 16, 2014 | 8:09 AM EDT
ILMN was upgraded from Neutral to Overweight, Piper Jaffray said. $192 price target. Channel checks suggest accelerating demand for HiS...
Here are three stocks to avoid at current levels.
Bullish
Aug 20, 2014 | 7:28 AM EDT
ILMN was upgraded from Neutral to Outperform, Wedbush said. $200 price target. Estimates also increased, following the recent Labcorp w...
Bullish
Apr 23, 2014 | 8:11 AM EDT
ILMN was upgraded from Hold to Buy, Maxim Group said. $205 price target. Clinical customers are accelerating adoption and the company i...

That Was the Week That Was Real Money Pro($)

Let's review.
I'd wait until the stock cools off to buy shares.
Its genetics work has the stock at crazy new heights

Columnist Conversations

GS has cleared the important hurdle on the way up which increases the odds for an eventual rally towards the 1...
A good quarterly report has sent shares of Calamos Asset Management (CLMS) sharply higher. CLMS was up about ...
Electronics distributor Ingram Micro (IM) reported better than 16% growth in its Q3 sending the stock up about...
Market posting decent day considering Ebola getting headlines again. Believe investors have learned not to pa...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.